Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs.
Nishiyama
Nobuhiro
N
Department of Phramaceutics and Pharmaceutical Chemistry, University of Utah, UT, USA.
Kataoka
Kazunori
K
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002945:Cisplatin / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use; D004337:Drug Carriers; D006801:Humans; D008823:Micelles; D009369:Neoplasms / Q000378:metabolism; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use; D010778:Photochemotherapy; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use; D014018:Tissue Distribution
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004337:Drug Carriers; D008823:Micelles; C474518:PEG-PAsp(Dox); D010455:Peptides; D011092:Polyethylene Glycols; D004317:Doxorubicin; D002945:Cisplatin